Stock Information

Corporate Profile

NLS Pharmaceutics is engaged in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders.
Lead product candidate, Quilience® is under clinical development to treat excessive daytime sleepiness (EDS) and cataplexy in narcolepsy

Sign up for company news

Your Name (required)

Your Email (required)

Your Company

Your Telephone